Germany, Sept. 4 -- Germany based Biotest GmbH & Co. KGaA has secured contract from AOK Sachsen - Anhalt for Pharmaceutical products - drug discount agreement according to Section 130a Paragraph 8 SGB V in conjunction with Section 130c Paragraph 1 SGB V for the drugs Haemoctin SDH (B02BD02) and Haemonine (B02BD04) for the treatment of hemophilia . The value of the contract is not disclosed .
Published by HT Digital Content Services with permission from Pivotal Sources....